Skip to content.

Spotlight

What do Founders worry about?

Reflections on CogX Founder Roundtable

Read the article >

A computing impasse – the investments we make now will define our future

Read the article >

Why we invested in Brytlyt?

Read the article >

Brytlyt raises $5m to continue its impressive growth in the Real-Time Data Analytics Sector

Silicon Canals

Read the article >
What's happening in biotech?

On not downclimbing – the prospects for early stage biotech remain bright

Read the article >

Why we invested in Carbon Re?

Read the article >

Bringing immuno-oncology cell therapies to the masses – are we (nearly) there yet?

Read the article >
Will the boom last?

A window to the past: is the investment boom in biotech going to last?

Read the article >
On the UK biotech public market

Over the Hill and (still) far away for UK biotechs

Read the article >

Why you should consider manufacturing from the start of the biotech R&D process

Read the article >

Are you looking for advice from an experienced #deeptech investor?

Silicon Republic

Read the article >
How to fund biotechs?

An evolution in early stage gene therapy funding models

Read the article >